Yesterday's move of MSLP should give confidence to traders and investors who will notice the strength of the 200DMA and the 50DMA. The stock has finally crossed $6.0 after about a month. The next level to watch out is $6.5 and it is expected that, if volumes rise, this may happen soon. A fresh march to the recent highs of $8.0 may then begin. It is important to note that the volume yesterday was nothing great (almost a third of the 3 month average). So one should keep a watch on any major change in that metric. Of course, if $6.5 is crossed and held for a few days, then the confirmation of completion of retracement, and beginning of uptrend will be there. Signs are there, and the fundamentals are also changing for the better as Muscle Pharm is beginning to do better things on the profitability front. Cleaning of debt from the balance sheet and cost cutting, through innovative methods of marketing / selling by use of social media, will make the 4th quarter of 2012 and the 1st quarter results of 2013 a very interesting read. With full year tentative figures of $78M for sales for 2012, and projection for 2013 being $100M, these results will make the investors understand whether the management is working towards fulfilling its promises. If the net margins turn positive, then the stock will not look back easily. Perhaps some insiders already know that the tables are about to turn and hence are accumulating at every dip. No wonder, timewise, the retracements do not last much. Further, the listing in Q2'13 will give a fillip to the stock fortunes as the volumes will improve. Other big investors will like to have a slice of the pie. In fact, this year will be significant for the company. If the management walks the talk, investors will be rewarded.